QuantaMatrix
QuantaMatrix Inc. is a leading in-vitro diagnostics company founded in 2010, specializing in microbiology, molecular biology, and immunoassay solutions. The company focuses on innovative platforms such as rapid antimicrobial susceptibility testing (dRAST), early detection of Alzheimer's disease, and prognostic kits for cardiovascular diseases. Its mission is to save lives, improve patient health, reduce healthcare costs, and fight antimicrobial resistance through cutting-edge diagnostic solutions.
Industries
Nr. of Employees
medium (51-250)
QuantaMatrix
Seoul, Seoul-t'ukpyolsi, South Korea, Asia
Products
Rapid direct antimicrobial susceptibility test (blood-culture to MIC)
An in-vitro diagnostic system that performs direct phenotypic susceptibility testing from positive blood cultures and reports MIC-based results in ~4 hours using microfluidics, agarose immobilization and time-lapse microscopy.
Blood-based multi-marker Alzheimer's disease assay
A plasma-based multiplex immunoassay for early detection/prediction of Alzheimer's disease by measuring multiple blood biomarkers and applying an algorithm to infer pathological amyloid beta accumulation.
Rapid tuberculosis drug susceptibility test
A rapid drug susceptibility assay for Mycobacterium tuberculosis designed to reduce time to drug susceptibility results for tuberculosis management.
Cardiovascular prognostic biomarker panels
Multiplex biomarker panels intended to predict early heart failure risk and prognosis after acute myocardial infarction using novel biomarker candidates.
Rapid direct antimicrobial susceptibility test (blood-culture to MIC)
An in-vitro diagnostic system that performs direct phenotypic susceptibility testing from positive blood cultures and reports MIC-based results in ~4 hours using microfluidics, agarose immobilization and time-lapse microscopy.
Blood-based multi-marker Alzheimer's disease assay
A plasma-based multiplex immunoassay for early detection/prediction of Alzheimer's disease by measuring multiple blood biomarkers and applying an algorithm to infer pathological amyloid beta accumulation.
Rapid tuberculosis drug susceptibility test
A rapid drug susceptibility assay for Mycobacterium tuberculosis designed to reduce time to drug susceptibility results for tuberculosis management.
Cardiovascular prognostic biomarker panels
Multiplex biomarker panels intended to predict early heart failure risk and prognosis after acute myocardial infarction using novel biomarker candidates.
Services
Distribution network support
Maintenance of a commercial distribution network and regional contact support for product information and distribution.
Provision of reagent safety and technical documentation
Provision of material safety data sheets and technical files for diagnostic reagent kits and panels.
Distribution network support
Maintenance of a commercial distribution network and regional contact support for product information and distribution.
Provision of reagent safety and technical documentation
Provision of material safety data sheets and technical files for diagnostic reagent kits and panels.
Expertise Areas
- Rapid antimicrobial susceptibility testing (phenotypic)
- Clinical microbiology diagnostics
- Microfluidic assay design and implementation
- Time-lapse microscopy and image-based analysis
Key Technologies
- Microfluidics
- Time-lapse microscopic imaging
- Phenotypic MIC-based AST
- Dried reagent/antibiotic panels